|Articles|August 4, 2004
Scott Whitcup, MD, leads Allergan R&D efforts; Schultz oversees U.S. business unit
Allergan Inc. announces the appointment of Scott Whitcup, MD, to executive vice president, research and development, and Joseph Schultz to senior vice president of Allergan's U.S. ophthalmology business unit.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
4
AAO 2025: A study of retinal vasculitis events with intravitreal agents
5














































.png)


